Polar delivers again in Covid 19 Convalescent Plasma Trial

Today another 100 Blood Plasma Systems were finished by the team in the Warminster factory. Extra shifts were put on over the Bank Holiday to keep ahead of schedule.

Whilst Oxford Univesity is leading the way the US Food & Drug Administration (FDA) has issued guidance for trials of the process.

Already accepted in China the use of antibody-rich plasma has reportedly been very beneficial for many patients.

In the UK, thousands of recovered Covid-19 patients have volunteered to give plasma for the trials, and the collection and transport using Polar Thermal Blood Plasma Systems is being scaled up.

It is important to understand that this is not being put forward as a vaccine or cure, but there is significant hope that it may reduce the symptoms and slow down the effect of the virus.